251 related articles for article (PubMed ID: 8698868)
21. Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro.
Martin A; Foxall T; Blumberg JB; Meydani M
Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):429-36. PubMed ID: 9102160
[TBL] [Abstract][Full Text] [Related]
22. Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease.
Lopes-Virella MF
Eur Heart J; 1993 Dec; 14 Suppl K():118-24. PubMed ID: 8131779
[TBL] [Abstract][Full Text] [Related]
23. Monocyte superoxide production is inversely related to normal content of alpha-tocopherol in low-density lipoprotein.
Cachia O; Léger CL; Descomps B
Atherosclerosis; 1998 Jun; 138(2):263-9. PubMed ID: 9690909
[TBL] [Abstract][Full Text] [Related]
24. Vitamin E, oxidative stress, and inflammation.
Singh U; Devaraj S; Jialal I
Annu Rev Nutr; 2005; 25():151-74. PubMed ID: 16011463
[TBL] [Abstract][Full Text] [Related]
25. High dose supplementation of RRR-alpha-tocopherol decreases cellular hemostasis but accelerates plasmatic coagulation in type 2 diabetes mellitus.
Ferber P; Moll K; Koschinsky T; Rösen P; Susanto F; Schwippert B; Tschöpe D
Horm Metab Res; 1999 Dec; 31(12):665-71. PubMed ID: 10668920
[TBL] [Abstract][Full Text] [Related]
26. Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells.
Ganji SH; Qin S; Zhang L; Kamanna VS; Kashyap ML
Atherosclerosis; 2009 Jan; 202(1):68-75. PubMed ID: 18550065
[TBL] [Abstract][Full Text] [Related]
27. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment.
Desfaits AC; Serri O; Renier G
Diabetes Care; 1998 Apr; 21(4):487-93. PubMed ID: 9571329
[TBL] [Abstract][Full Text] [Related]
28. alpha-tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals.
van Tits LJ; Demacker PN; de Graaf J; Hak-Lemmers HL; Stalenhoef AF
Am J Clin Nutr; 2000 Feb; 71(2):458-64. PubMed ID: 10648258
[TBL] [Abstract][Full Text] [Related]
29. The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study.
Jialal I; Fuller CJ; Huet BA
Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):190-8. PubMed ID: 7749825
[TBL] [Abstract][Full Text] [Related]
30. Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation.
Thomas SR; Neuzil J; Stocker R
Arterioscler Thromb Vasc Biol; 1996 May; 16(5):687-96. PubMed ID: 8963727
[TBL] [Abstract][Full Text] [Related]
31. Effect of alpha-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies.
Li D; Devaraj S; Fuller C; Bucala R; Jialal I
J Lipid Res; 1996 Sep; 37(9):1978-86. PubMed ID: 8895064
[TBL] [Abstract][Full Text] [Related]
32. Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation.
Devaraj S; Adams-Huet B; Fuller CJ; Jialal I
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2273-9. PubMed ID: 9351400
[TBL] [Abstract][Full Text] [Related]
33. Palmitate promotes monocyte atherogenicity via de novo ceramide synthesis.
Gao D; Pararasa C; Dunston CR; Bailey CJ; Griffiths HR
Free Radic Biol Med; 2012 Aug; 53(4):796-806. PubMed ID: 22640955
[TBL] [Abstract][Full Text] [Related]
34. Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL.
Desfaits AC; Serri O; Renier G
Metabolism; 1997 Oct; 46(10):1150-6. PubMed ID: 9322798
[TBL] [Abstract][Full Text] [Related]
35. Triggering of inflammatory response by myeloperoxidase-oxidized LDL.
Boudjeltia KZ; Legssyer I; Van Antwerpen P; Kisoka RL; Babar S; Moguilevsky N; Delree P; Ducobu J; Remacle C; Vanhaeverbeek M; Brohee D
Biochem Cell Biol; 2006 Oct; 84(5):805-12. PubMed ID: 17167545
[TBL] [Abstract][Full Text] [Related]
36. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients.
Devaraj S; Jialal I
Free Radic Biol Med; 2000 Oct; 29(8):790-2. PubMed ID: 11053781
[TBL] [Abstract][Full Text] [Related]
37. Gliclazide decreases low-density lipoprotein oxidation and monocyte adhesion to the endothelium.
Renier G; Desfaits AC; Serri O
Metabolism; 2000 Feb; 49(2 Suppl 1):17-22. PubMed ID: 10693915
[TBL] [Abstract][Full Text] [Related]
38. Oxidized lipid accumulates in the presence of alpha-tocopherol in atherosclerosis.
Upston JM; Terentis AC; Morris K; Keaney Jr JF; Stocker R
Biochem J; 2002 May; 363(Pt 3):753-60. PubMed ID: 11964176
[TBL] [Abstract][Full Text] [Related]
39. Oxidized low density lipoprotein-induced LFA-1-dependent adhesion and transendothelial migration of monocytes via the protein kinase C pathway.
Mine S; Tabata T; Wada Y; Fujisaki T; Iida T; Noguchi N; Niki E; Kodama T; Tanaka Y
Atherosclerosis; 2002 Feb; 160(2):281-8. PubMed ID: 11849649
[TBL] [Abstract][Full Text] [Related]
40. Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers.
van Tits LJ; de Waart F; Hak-Lemmers HL; van Heijst P; de Graaf J; Demacker PN; Stalenhoef AF
Free Radic Biol Med; 2001 May; 30(10):1122-9. PubMed ID: 11369502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]